FDA
Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- EMTRICITABINE 200MG; RILPIVIRINE HYDROCHLORIDE EQ 25MG BASE; TENOFOVIR DISOPROXIL FUMARATE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EMTRICITABINE 200MG; RILPIVIRINE HYDROCHLORIDE EQ 25MG BASE; TENOFOVIR DISOPROXIL FUMARATE 300MG · TabletANDA220232-001 · Prescription
- EMTRICITABINE 200MG; RILPIVIRINE HYDROCHLORIDE EQ 25MG BASE; TENOFOVIR DISOPROXIL FUMARATE 300MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA208452.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.